Topical ASP-1001 (Contrast Media Formulation) and the Acute Response to Nasal Allergen Challenge (NAC)

NCT00791102 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Allergic Rhinitis

Interventions

DRUG: ASP-1001 nasal spray
DRUG: Placebo for ASP-1001

Sponsor

University of Chicago

Collaborators

[object Object]